Related Experiment Videos
RET and neuroendocrine tumors
Masatoshi Ichihara1, Yoshiki Murakumo, Masahide Takahashi
1Department of Pathology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan. ichihara@med.nagoya-u.ac.jp
Cancer Letters
|March 12, 2004
Summary
Glial cell line-derived neurotrophic factor (GDNF) and its receptor RET are crucial for neuronal development. Dysregulation of RET signaling causes neuroendocrine diseases like thyroid cancer and Hirschsprung's disease.
Area of Science:
- Neuroscience
- Molecular Biology
- Oncology
Background:
- Glial cell line-derived neurotrophic factor (GDNF) and its receptor RET are vital for neuronal survival and differentiation.
- The GDNF-RET system is essential for kidney and peripheral nervous system development.
- RET signaling pathways include RAS/ERK, PI3K/AKT, p38 MAPK, and JNK.
Purpose of the Study:
- To review the molecular mechanisms of RET activation in neuroendocrine tumors.
- To explore the physiological roles and signal transduction of RET tyrosine kinase.
- To understand RET's involvement in human neuroendocrine diseases.
Main Methods:
- Literature review of studies on GDNF, RET signaling, and neuroendocrine diseases.
- Analysis of gene ablation studies and mutation-associated disease phenotypes.
- Examination of RET's role in signaling pathways and tyrosine kinase activity.
Main Results:
- Constitutive RET activation by mutations or rearrangements causes papillary thyroid carcinoma, MEN 2A, and MEN 2B.
- RET dysfunction due to mutations leads to Hirschsprung's disease.
- Specific RET mutations dictate disease phenotype by altering kinase activity and gene expression.
Conclusions:
- RET tyrosine kinase plays a critical role in neuroendocrine tumor development and congenital diseases.
- Understanding RET activation mechanisms is key to developing targeted therapies for RET-associated disorders.
- The review synthesizes current knowledge on RET signaling in health and disease.